Wanbangde Pharmaceutical Holding Group Co., Ltd. (SHE:002082)
China · Delayed Price · Currency is CNY 15.74
+0.14 (0.90%)
Feb 3, 2026, 3:04 PM CST
SHE:002082 Revenue
Wanbangde Pharmaceutical Holding Group had revenue of 439.15M CNY in the quarter ending September 30, 2025, with 36.51% growth. This brings the company's revenue in the last twelve months to 1.39B, down -13.26% year-over-year. In the year 2024, Wanbangde Pharmaceutical Holding Group had annual revenue of 1.44B, down -6.39%.
Revenue (ttm)
1.39B
Revenue Growth
-13.26%
P/S Ratio
6.88
Revenue / Employee
925.00K
Employees
1,499
Market Cap
9.54B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.44B | -98.57M | -6.39% |
| Dec 31, 2023 | 1.54B | -244.49M | -13.69% |
| Jan 1, 2023 | 1.79B | -144.17M | -7.47% |
| Jan 1, 2022 | 1.93B | -11.77B | -85.91% |
| Dec 31, 2020 | 13.70B | -2.99B | -17.91% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition